Hormonal Contraceptives Market (By Product Type: Oral Contraceptive Pills, Vaginal Rings, Emergency Contraceptive Pills, Transdermal Patches, Injectable Birth Control; By Hormone: Combined Hormonal Contraceptive, Progestin-only Contraceptive; By End User: Hospitals, Clinics, Household) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The global hormonal contraceptives market size is expected to reach around US$ 26.5 billion by 2026 growing at remarkable CAGR around 4.2% during the forecast time frame 2019 to 2026.

Contraceptives may be considered a preventive medicine or device. Contraceptives can be hormonal and non-hormonal in different kinds. The form of contraceptive in the endocrine system to regulate birth is hormonal contraceptive. The hormonal contraception regulates hormonal changes in the menstrual cycle of the female through the use of various hormones similar to progesterone and estrogen. As the incidence of issues in women's health such as PCOS, delayed child-bearing and increasing public awareness of population control increases, the demand for hormonal contraceptives rises. As a result of increasing technological progresses, a high prevalence of obesity, and an increase in PCOS worldwide, the global hormonal contraceptives market has seen a relatively strong growth.

Different kinds of hormone contraception techniques, including oral pill, skin patch, intrauterine device (IUD), injection and implantation of rod under the skin are now accessible on the market. The hormonal exposure is determined whether it is constant or intermittent, depending on the form of hormonal contraception. The prevention of implanting fertilized egg in women's wombs (uterus) begins with all hormonal contraception methods and starts developing or preventing sperm and egg from fertilizing. New and enhanced hormonal contraception techniques are being created as, under multiple conditions, the efficacy of several techniques may vary.

The report provides analysis of global hormonal contraceptives market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

Market Insights

The main drivers that accelerate growth are increasing awareness of contraception methods in emerging economies, investments from key players in the creation of innovative equipment and governmental initiatives to enhance access to products. The worldwide hormone contraceptives market will grow during the forecast period on a constant CAGR.

A significant factor which is supposed to drive the market during the forecast period is the increase in the global infertility rate. Additionally, the international market is anticipated to increase other factors such as increased lifestyles, elevated incidence of PCOS, obesity and late childbirth owing to economic stability. In addition, awareness of population control in developed nations and numerous family planning public programs in several developing nations are additional significant considerations to boost the worldwide hormone contraceptive market. Worldwide, women are commonly used in hormonal contraception. Hormonal contraception is adopted for birth control owing to the community's knowledge in making accurate choices on reproductive and sexual health. Increases in women's global population, urbanization and increased awareness of hormone contraception and encourages NGOs and governments to promote hormone contraception are the driving force behind the growth of the hormones market. Instead of continuous contraception, implementation of temporary and low price contraceptive practices is the key driving force of the worldwide hormonal contraception industry. Furthermore, the increase in public awareness of population control in various developed and developing countries drives this market's growth.

Governments and market players' awareness programs assist increase demand and, consequently, the contraceptives market. The progress in hormonal contraception is anticipated to further increase market growth with increased effectiveness and less side impact. In addition, health problems connected with teenage pregnancies, awareness of advanced techniques of contraception and an increasing application of oral pills to discourage unplanned pregnancy contribute to market development. Partnerships and research and development collaborations and fresh products' commercialization are main strategy for increasing their market share taken by important players.

The segment of contraceptive pills is projected to maintain its prevalence over the prediction period. The segment's development can be ascribed to an easy and simple management mode, easy access to a broad range of products, a high level of awareness about early entering market pills and high effectiveness with regard to timely use, of around 99 percent in comparison with long-acting appliances. In addition, the presence and growing penetration of various major players in the field in emerging countries will make a contribution to the growth of the segment. Due to growing use of long-acting techniques for contraception IUDs are likely to experience the quickest development during the forecast period. Some of the variables attributable to the notable development of the segment are over 99.0% efficiency, long action periods, no impact of a device on breastfeeding, and ordinary fertility following disposal. Long-acting methods like IUD and vaginal rings have gained popularity in the US. Their adoption has been increasing since the last decade. This may be due to continuous increases in copay and consequently improved affordability for oral contraceptive pills. Kyleena, Mirena, Skyla, and Liletta are the main IUDs currently available in the U.S. market. On the hormonal base, the market is transformed into a mixed hormonal contraceptive and progestin-only. The broad availability of mixed hormonal contraceptives and better efficacy to avoid pregnancy dominate the market. Combined hormone contraceptive products

Regional Stance

In 2018, North America is the dominating market and is anticipated to remain in the forecast period. This is due to elevated per capita incomes, elevated market presence, better understanding of sexual health and a wide variety of unintentional pregnancies. Obesity, high population awareness, infertility prevalence and PCOS in the region are the key drivers for market stimulus in North America. In the predicted era, Asia Pacific is expected to see most rapid development. The significant variables complementing regional development include a large fertile population, the launch of fresh female contraception devices, the increase in market players' investment and powerful economical development. Countries like China, India and Japan provide significant market opportunities because of population growth, increased lifestyle-related disease prevalence, increased infertility, PCOSs and family planning government programs.

Challenges and Opportunities

Some variables probable to curb the worldwide hormonal contraceptive market during a projected period are alternative techniques of contraception, side-effects of hormonal medicines, and absence of social recognition in several developing nations.

Market Segmentation

Global Hormonal Contraceptives Market, By Product Type

  • Oral Contraceptive Pills
  • Vaginal Rings
  • Emergency Contraceptive Pills
  • Transdermal Patches
  • Injectable Birth Control

Global Hormonal Contraceptives Market, By Hormone

  • Combined Hormonal Contraceptive
  • Progestin-only Contraceptive

Global Hormonal Contraceptives Market, By End User

  • Hospitals
  • Clinics
  • Household

Global Hormonal Contraceptives Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Hormonal Contraceptives Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Hormonal contraceptives market segments with market dynamics and their impact. The report also covers basic technology development policies.

Key Players & Strategies

The hormonal contraceptives market consists of key vendors such as Allergan; Pfizer; Afaxys, Inc.; Agile Therapeutics; Bayer AG; Merck & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; and Apothecus Pharmaceutical Corporation. In order to capture a important place in the worldwide market, key players on the worldwide market adopt strategies such as fusion and acquisitions, technological growth and geographical extension.

The main approaches that industry respondents take to improve their market share are approval and marketing of different goods, improving geographical reach and extending the implementation of existing goods.


Frequently Asked Questions

The hormonal contraception regulates hormonal changes in the menstrual cycle of the female through the use of various hormones similar to progesterone and estrogen.

The main drivers that accelerate growth are increasing awareness of contraception methods in emerging economies, investments from key players in the creation of innovative equipment and governmental initiatives to enhance access to products.

According to Acumen Research and Consulting, the hormonal contraceptives market value is anticipated to be worth around US$ 26.5 billion in 2026.

The hormonal contraceptives market is anticipated to grow over 4.2% CAGR during the forecast period 2019 to 2026.

North America held maximum share in 2018 for hormonal contraceptives market.

Asia Pacific is projected to grow at a fast pace during forecast period in the hormonal contraceptives market.

Some variables probable to curb the worldwide hormonal contraceptive market during a projected period are alternative techniques of contraception, side-effects of hormonal medicines, and absence of social recognition in several developing nations.

Cart Summary


60